IT Orange | IT桔子

ORIC Pharmaceuticals Receives USD 25 Million Strategic Investment

ORIC Pharmaceuticals is an American clinical-stage biopharmaceutical developer. The company mainly develops new treatments for tumor cell drug resistance and provides treatment options for patients with relapsed cancer. Although rapidly developing targeted therapy technologies have substantially improved patient outcomes, cancers often become resistant to chemotherapy drugs, and relapsed patients often lack further treatment options. Recently,

ORIC Pharmaceuticals Receives USD 25 Million Strategic Investment Read More »

Jiangsu Waycare completed hundreds of millions of yuan in Series B financing

Vicare Pharmaceutical Technology Co., Ltd. is based on the research and development of innovative drugs, the transfer of generic drug technology, and the production and sales of pharmaceutical intermediates. The company has a complete R&D, production and sales system, has well-equipped synthesis, preparation and drug analysis laboratories, and has established industrialization partnerships with many manufacturers,

Jiangsu Waycare completed hundreds of millions of yuan in Series B financing Read More »

Dean Diagnostics (300244.SZ): Gloria plans to acquire 100% equity of Alta in stages

Alta Technology is a biological analysis and testing organization, dedicated to the research and development, production and sales of First Standard® domestically owned organic standards and stable isotope labeling reagents. It has obtained 2 trademark authorizations and 5 invention patents, and has developed thousands of More than a variety of pure organic chemical standard reference

Dean Diagnostics (300244.SZ): Gloria plans to acquire 100% equity of Alta in stages Read More »

House of Blueberry received a strategic investment of approximately US$6 million

House of Blueberry is a metaverse avatar design provider. Focus on designing wearable devices and clothing for 3D virtual spaces, and provide players with personal avatars and avatars. Recently, House of Blueberry received a strategic investment of approximately US$6 million. This article is transferred from: https://www.itjuzi.com/investevent/13739559 This site is only for collection, and the copyright

House of Blueberry received a strategic investment of approximately US$6 million Read More »

Shenliu Micro completed the A-round financing of 100 million yuan

Shenliu Microintelligence focuses on the design of domestic independent controllable GPU chips. Based on the computing architecture and software system with independent intellectual property rights, it provides high-performance GPU chips and solutions with functions such as graphics rendering, image processing, virtual reality, artificial intelligence, and supercomputing. solution to fill the gap in domestic mid-to-high-end GPU

Shenliu Micro completed the A-round financing of 100 million yuan Read More »

Baijiayun landed on Nasdaq, and China ushered in the first audio and video SaaS company listed on the US stock market

On December 25, Baijiayun, a domestic audio and video technology service provider, announced the formal completion of the merger and listing transaction with Fuwei Films (Holdings) Co., Ltd. So far, Baijiayun has officially landed on NASDAQ and has become the first stock in China’s audio and video SaaS. The company’s new stock symbol will be

Baijiayun landed on Nasdaq, and China ushered in the first audio and video SaaS company listed on the US stock market Read More »

Huiwei successfully completed the A-round financing of tens of millions of yuan

Huiwei Intelligent Medical is an AI medical and health service provider. It uses “edge computing” and “artificial intelligence” as its core technologies. It mainly provides medical institutions with diagnosis, treatment, rehabilitation medical equipment and medical services. At present, it has developed AI-assisted diagnosis and treatment products. And AI health management products. Recently, Huiwei successfully completed

Huiwei successfully completed the A-round financing of tens of millions of yuan Read More »

Baili Tianheng’s public offering on the Shanghai Stock Exchange

Baili Tianheng is a platform integrating pharmaceutical research and development, production and sales, and is committed to providing new varieties to solve patients’ health problems. Affiliated to Sichuan Baili Tianheng Pharmaceutical Co., Ltd. Baili Tianheng went public on the Shanghai Stock Exchange today. This article is reproduced from: https://www.itjuzi.com/pre-ipo?comname=%E7%99%BE%E5%88%A9%E5%A4%A9%E6%81%92 This site is only for collection,

Baili Tianheng’s public offering on the Shanghai Stock Exchange Read More »

Danma Biotech completed the A-round financing of nearly 20 million U.S. dollars

Danma Bio is an innovative drug developer. Danma Bio has established its own GAMID® (Genetics-centric And Multi-omics Integrated Data) target discovery platform, based on massive human disease genome-wide association study (GWAS) data , and integrate the growing multi-omics data such as proteome GWAS and transcriptome GWAS, large-scale and systematic application of Mendelian randomization (Mendelian Randomization)

Danma Biotech completed the A-round financing of nearly 20 million U.S. dollars Read More »

Tianjin Telecom plans to increase capital and share by 300 million yuan to introduce strategic investors

Tianjin Telecom is a business company under 35Internet that is carrying out strategic transformation and upgrading to the photovoltaic industry. The current main project is the new energy 5GW heterojunction battery project. The company recently introduced a total of 13 strategic investors including Sichuan Xinhongxing Group Co., Ltd., Hainan Jiayu Technology Co., Ltd., and Chengdu

Tianjin Telecom plans to increase capital and share by 300 million yuan to introduce strategic investors Read More »